In a filing, Sotera Health Co revealed its Chairman & CEO Petras Michael B. Jr. unloaded Company’s shares for reported $7.14 million on Dec 08 ’25. In the deal valued at $16.45 per share,434,104 shares were sold. As a result of this transaction, Petras Michael B. Jr. now holds 0 shares worth roughly $0.0.
Then, Petras Michael B. Jr. sold 315,896 shares, generating $5,196,489 in total proceeds. Upon selling the shares at $16.45, the Chairman & CEO now owns 552,790 shares.
Before that, Michael B. Petras, Jr. bought 750,000 shares. Sotera Health Co shares valued at $12,562,500 were divested by the Chairman, CEO at a price of $16.75 per share.
William Blair initiated its Sotera Health Co [SHC] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. Goldman also remained covering SHC and has increased its forecast on May 05, 2025 with a “Buy” recommendation from previously “Neutral” rating. Goldman started covering the stock on December 06, 2024. It rated SHC as “a Neutral”.
Price Performance Review of SHC
On Friday, Sotera Health Co [NASDAQ:SHC] saw its stock jump 0.35% to $17.17. Over the last five days, the stock has gained 2.02%. Sotera Health Co shares have risen nearly 31.27% since the year began. Nevertheless, the stocks have risen 25.51% over the past one year. While a 52-week high of $17.78 was reached on 11/04/25, a 52-week low of $9.53 was recorded on 04/09/25.
Levels Of Support And Resistance For SHC Stock
The 24-hour chart illustrates a support level at 17.02, which if violated will result in even more drops to 16.88. On the upside, there is a resistance level at 17.32. A further resistance level may holdings at 17.48.
How much short interest is there in Sotera Health Co?
A steep rise in short interest was recorded in Sotera Health Co stocks on 2025-11-28, growing by 0.47 million shares to a total of 7.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 7.15 million shares. There was a rise of 6.18%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 21, 2024 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $13 price target.
